<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04718610</url>
  </required_header>
  <id_info>
    <org_study_id>OSTEOCAN</org_study_id>
    <nct_id>NCT04718610</nct_id>
  </id_info>
  <brief_title>Heart Rate Variability, Vagus Nerve and Cancer</brief_title>
  <official_title>Effects of Vagus Nerve Osteopathic Stimulations on Heart Rate Variability of Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Henri Duffaut - Avignon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut de Formation en Ostéopathie du Grand Avignon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Henri Duffaut - Avignon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In France, new cancer cases keep on increasing with around 150 000 deaths yearly. Cancer&#xD;
      therapy research is constantly evolving. Indeed, several studies explore new treatments or&#xD;
      their combination with conventional cancer treatments. But, at the same time, complementary&#xD;
      and alternative medicines, as osteopathy, remain little explored upon their role in the&#xD;
      combination with conventional therapy.&#xD;
&#xD;
      Several studies showed indirect interaction between vagus nerve and cancer. Firstly, vagus&#xD;
      nerve regulates homeostasis and immunity by reducing systemic inflammation while maintaining&#xD;
      local inflammation and antitumor effects. Secondly, vagus nerve stimulation increases Heart&#xD;
      Rate Variability (HRV). Moreover, a higher HRV is associated with an improvement of vital&#xD;
      prognosis in cancer patients. Vagus nerve could be stimulated by noninvasive osteopathic&#xD;
      manipulations.&#xD;
&#xD;
      This prospective, monocentric and randomized study is a collaboration between the Centre&#xD;
      Hospitalier d'Avignon and the Institut de Formation en Ostéopathie du Grand Avignon. It&#xD;
      focuses on using noninvasive osteopathic mobilizations to stimulate vagus nerve. Indeed, this&#xD;
      study aims to evaluate effects of vagus nerve osteopathic stimulations on HRV in patients&#xD;
      with lung cancer, colorectal cancer, Non Hodgkin Lymphoma or Multiple Myeloma. More&#xD;
      specifically, this study will tell us whether vagus nerve noninvasive osteopathic&#xD;
      stimulations induce increase of HRV associated with a decrease of systemic inflammation and&#xD;
      an improvement of patient's quality of life.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 12, 2021</start_date>
  <completion_date type="Anticipated">January 12, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 12, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>For each cancer type, 30 patients will be included. These patients will be randomized into two groups.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Heart Rate Variability measured by SDNN (Standard Deviation of all NN intervals) from baseline to the end of osteopathic treatment</measure>
    <time_frame>up to 84 days</time_frame>
    <description>To assess the effect of vagus nerve osteopathic stimulations on Heart Rate Variability</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum concentration of C-Reactive Protein</measure>
    <time_frame>up to 84 days</time_frame>
    <description>To assess the effect of vagus nerve osteopathic stimulations on systemic inflammatory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to definitive improvement in global health status / QoL</measure>
    <time_frame>up to 84 days</time_frame>
    <description>To assess the effect of vagus nerve osteopathic stimulations on health related quality of life</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Colorectal Cancer</condition>
  <condition>Multiple Myeloma</condition>
  <condition>Non Hodgkin Lymphoma</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive only caner treatment. No osteopathic treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Osteopathic intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive cancer treatment associated with osteopathic intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Osteopathic intervention</intervention_name>
    <description>Nerve vagus stimulation</description>
    <arm_group_label>Osteopathic intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>CRP assessment</intervention_name>
    <description>Blood CRP will be assessed during trial</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Osteopathic intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>QLQ-C30 questionnaire</intervention_name>
    <description>Completion of QLQ-C30</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Osteopathic intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with lung cancer or colorectal cancer or Non Hodgkin Lymphoma or Multiple&#xD;
             Myeloma (Stade I à IV)&#xD;
&#xD;
          -  No previous treatment&#xD;
&#xD;
          -  HRV &lt; 70 ms&#xD;
&#xD;
          -  No osteopathic contraindication&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Vagotomy&#xD;
&#xD;
          -  Heart arrhythmia&#xD;
&#xD;
          -  Cancer recurrence&#xD;
&#xD;
          -  Consumption of coffee or tabac within 2 hours prior osteopathic treatment&#xD;
&#xD;
          -  Consumption of alcohol within 24 hours prior osteopathic treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Borhane SLAMA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Henri Duffaut - Avignon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierrick MARTINEZ, OsteopatheDO</last_name>
    <phone>+33432759392</phone>
    <email>pierrick.martinez10@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marilyne GRINAND, PhD</last_name>
    <phone>+33432759392</phone>
    <email>grinand.marilyne@ch-avignon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Henri Duffaut</name>
      <address>
        <city>Avignon</city>
        <zip>84000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Borhane SLAMA, MD</last_name>
      <phone>+33432759392</phone>
      <email>bslama@ch-avignon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Marilyne GRINAND, PhD</last_name>
      <phone>+33432759392</phone>
      <email>grinand.marilyne@ch-avignon.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 14, 2021</study_first_submitted>
  <study_first_submitted_qc>January 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>January 18, 2021</last_update_submitted>
  <last_update_submitted_qc>January 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cancer</keyword>
  <keyword>Vagus nerve stimulation</keyword>
  <keyword>Heart rate variability</keyword>
  <keyword>Osteopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

